Study of Panitumumab Efficacy in Patients With Recurrent and/or Metastatic Head and Neck Cancer
NCT00460265
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
658
Enrollment
INDUSTRY
Sponsor class
Conditions
Recurrent and/or Metastatic Head and Neck Cancer
Interventions
DRUG:
ARM 2
DRUG:
ARM 1
Sponsor
Amgen